Friday Pop Quiz #293
The correct answer is B. HLA-Cw6.  The case describes early-onset plaque psoriasis with a postive family history. HLA-Cw6 is associated with early onset (<40) psoriasis with positive family history, expressed in 90% of early onset patients and only 50% in late onset (7% in control population). The characteristics of Type I psoriasis are: early-onset, positive family history, HLA-Cw6. Ty …
Pentoxifylline Therapeutic Cheat Sheet
PentoxifyllinePentoxifylline is a methyl-xanthine derivative traditionally used to treat symptoms of peripheral vascular disease and has emerged as a valuable therapeutic agent in dermatology for its anti-inflammatory and immunomodulatory properties. We continue our series, Therapeutic Cheat Sheet, with a closer look at pentoxifylline, which is FDA-approved for the treatment of intermittent claudication and is …
Pentoxifylline
Patient Buzz Series: Cortisol Face
cortisol faceThere’s a new moniker for facial puffiness: “cortisol face.” As described in an article in Parade, cortisol face is a catch-all term for facial swelling due to elevated cortisol levels. The term became popular on TikTok to describe facial puffiness, roundness, and redness or flushing. Physicians quoted in the article pointed out the benefits of cortisol and recommended people talk to their d …
cortisol face
Friday Pop Quiz #289
The correct answer is C. Continue guselkumab, start topical steroids and low-dose methotrexate. Combination therapy with MTX and biologics may serve as an efficacious treatment for psoriasis patients with an inadequate response to DMARD monotherapy. Adjuvant topical therapy and low-dose methotrexate to guselkumab may help preserve duration of her response to guselkumab. The patient’s u …
error

Enjoy this blog? Please spread the word :)